A previous study found that high expression of the FGFR4 Arg388 allele was significantly associated with reduced overall survival and with an advanced tumor stage in HNSCC; data supporting our findings is available in the TCGA database [23]. This evidence concerns the gene FGFR4 and head and neck squamous cell carcinoma.